40255-50-3 Usage
Uses
Used in Pharmaceutical Industry:
3-[4-(4-Methoxyphenyl)piperazin-1-yl]propan-1-amine is used as a potential active pharmaceutical ingredient for its possible pharmacological properties. Its exact applications in medicine are yet to be determined, but as a phenylpiperazine derivative, it may be explored for its potential effects on the central nervous system or other therapeutic areas.
Used in Chemical Research:
In the field of chemical research, 3-[4-(4-Methoxyphenyl)piperazin-1-yl]propan-1-amine serves as a subject for studying the structure-activity relationships of phenylpiperazine compounds. Its unique structure may provide insights into the development of new drugs or the understanding of molecular interactions within biological systems.
Used in Material Science:
Although not explicitly mentioned in the provided materials, due to its amine and methoxy groups, 3-[4-(4-Methoxyphenyl)piperazin-1-yl]propan-1-amine could potentially be used in material science for the development of new polymers or as a component in the synthesis of other complex organic materials, given its ability to form various types of chemical bonds.
Check Digit Verification of cas no
The CAS Registry Mumber 40255-50-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,0,2,5 and 5 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 40255-50:
(7*4)+(6*0)+(5*2)+(4*5)+(3*5)+(2*5)+(1*0)=83
83 % 10 = 3
So 40255-50-3 is a valid CAS Registry Number.
InChI:InChI=1/C14H23N3O/c1-18-14-5-3-13(4-6-14)17-11-9-16(10-12-17)8-2-7-15/h3-6H,2,7-12,15H2,1H3/p+2
40255-50-3Relevant academic research and scientific papers
KAPPA OPIOID RECEPTOR EFFECTORS AND USES THEREOF
-
Paragraph 00052, (2013/03/28)
The present invention is a selective kappa opioid receptor effector, or a pharmaceutically acceptable salt thereof, useful for treating ethanol use disorder withdrawal, anxiety and/or depression, schizophrenia, mania or post-traumatic stress disorder.
Synthesis and biological evaluation of oxazole derivatives as T-type calcium channel blockers
Lee, Jie Eun,Koh, Hun Yeong,Seo, Seon Hee,Baek, Yi Yeon,Rhim, Hyewhon,Cho, Yong Seo,Choo, Hyunah,Pae, Ae Nim
scheme or table, p. 4219 - 4222 (2010/09/04)
T-type calcium channel is one of therapeutic targets for the treatment of cardiovascular diseases and neuropathic pain. In this study, as a part of our ongoing efforts to develop potent T-type calcium channel blockers, we designed oxazole derivatives subs
POTENTIAL NEUROLEPTICS OF THE ORTHOPRAMIDE SERIES; SYNTHESIS OF N-(3-(TERT.AMINO)PROPYL)-5-SULFAMOYL-2-METHOXYBENZAMIDES
Valenta, Vladimir,Vlkova, Marie,Holubek, Jiri,Svatek, Emil,Metysova, Jirina,Protiva, Miroslav
, p. 797 - 808 (2007/10/02)
Heating ethyl 5-sulfamoyl-2-methoxybenzoate with a series of twelve 3-(tert.amino)propylamines (IIIa-IIIl) afforded the title compounds IIa-IIl which were transformed to salts and subjected to pharmacological screening as potential neuroleptics of the sulpiride series.Only compounds IId (hydrogen oxalate, VUFB-15 453) and IIg (methanesulfonate, VUFB-15 397) showed indications of the desired psychotropic activity.
